What made the difference?
As a 23 year old, hearing the words, "You might have cancer," is terrifying. My doctor gave me an option of having my thyroid removed to get a clearer diagnosis. With the Afirma test I had a benign result and was able to avoid surgery. I felt a great sense of relief and confidence in the test. Grateful for the outcome.
Real People
Real Answers.
Afirma Patient
This is the Age of Evidence.
Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.

Veracyte gives patients a clearer path for the future.

We are leading in the Age of Evidence.
our impact
The Age
of Evidence
Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.
Learn More >
New data published in The Lancet Respiratory Medicine show that the Envisia Genomic Classifier improves diagnosis of IPF
learn more >
Bonnie Anderson, Veracyte CEO interview with Bill Vick/PF Warriors about the Envisia Genomic Classifier and plans to transform IPF/ILD diagnosis


latest news
news and updates